A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
about
Immunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerEpigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells.Increased frequencies of circulating and tumor-resident Vδ1+ T cells in patients with diffuse large B-cell lymphoma.A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells.[Nectins and nectin-like receptors DNAM-1 and CRTAM: new ways for tumor escape].
P2860
A quantitative deficiency in peripheral blood Vγ9Vδ2 cells is a negative prognostic biomarker in ovarian cancer patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A quantitative deficiency in p ...... er in ovarian cancer patients.
@ast
A quantitative deficiency in p ...... er in ovarian cancer patients.
@en
A quantitative deficiency in p ...... er in ovarian cancer patients.
@nl
type
label
A quantitative deficiency in p ...... er in ovarian cancer patients.
@ast
A quantitative deficiency in p ...... er in ovarian cancer patients.
@en
A quantitative deficiency in p ...... er in ovarian cancer patients.
@nl
prefLabel
A quantitative deficiency in p ...... er in ovarian cancer patients.
@ast
A quantitative deficiency in p ...... er in ovarian cancer patients.
@en
A quantitative deficiency in p ...... er in ovarian cancer patients.
@nl
P2093
P2860
P1433
P1476
A quantitative deficiency in p ...... ker in ovarian cancer patients
@en
P2093
Aurélie Thedrez
Benoit Dessarthe
Florian Cabillic
Isabelle Jaffre
Jean Levêque
Pascale Daniel
Sébastien Henno
Véronique Catros
P2860
P304
P356
10.1371/JOURNAL.PONE.0063322
P407
P577
2013-05-23T00:00:00Z